INDO-MIM Q1 FY27: Tracking the New World's Largest MIM Maker Through Its Debut Quarter
With a July listing and 28% FY26 growth, the precision engineering leader eyes 10-15% FY27 expansion. Q1 will be the Street's first glimpse of post-IPO execution in a newly liquid stock.
The Setup: Why Q1 Matters
INDO-MIM listed in July 2026 at a 45% premium to IPO price, completing a two-decade journey from a private precision-engineering shop to the world's largest Metal Injection Moulding (MIM) manufacturer by revenue. In FY26, the company shipped ₹4,321 Cr in revenue (up 28% YoY) with a 12% net margin and generated ₹534 Cr PAT (up 26% YoY). It serves 1,100+ customers across automotive, aerospace, defence, medical, and consumer sectors, with 91% repeat revenue and 77% earned offshore — a capital-light, cash-generative export model.
Q1 FY27 is the first quarterly test of post-IPO operating momentum and Street confidence. The company has guided 10-15% revenue growth for FY2027 and stable EBITDA margins, anchored to a recovery in aerospace/defence order flow and steady automotive. Watch whether new liquidity drives working capital tightness, whether execution hews to the 14-year 20%+ revenue CAGR, and how the fresh capital is deployed.
~₹1,100-1,150 Cr
On 10-15% FY2027 growth guidance; Q1 typically seasonal vs. H2
~₹135-150 Cr
On ~12% net margin (FY26 run-rate); order mix and forex headwind watch
TBD
Will signal H2 visibility; aerospace/defence booking pace vs. automotive stability
Strong vs. Weak Q1
A strong quarter would show revenue ₹1,125 Cr+ and net profit ₹140 Cr+, signalling order inflows are holding and H2 aerospace/defence bookings are on-track. Export realisations steady; capex deployment for 5-year growth plan is disciplined. A weak print would be revenue below ₹1,050 Cr or net profit below ₹130 Cr, suggesting order delays, forex headwind, or operational friction post-listing. Watch also for working capital tightness (inventory/receivables) as new scale is absorbed.
Street View
Since Last Quarter
No P&L delivery between Q4 FY26 close (end-May 2026) and this preview, so trajectory cannot be bench-marked vs. recent ops. Filings since the IPO close (July 30, 2026):
1 · Trading window closure (July 30, 2026)
Routine pre-results blackout. Window to reopen 48 hours post-result announcement (Aug 19, 2026 onwards).
2 · Fair Disclosure Code adoption (Aug 7, 2026)
Compliance milestone. INDO-MIM adopted SEBI UPSI fair disclosure code; KMPs authorized for materiality thresholds — routine post-listing governance.
3 · Board meeting scheduled (Aug 17, 2026)
To approve Q1 FY27 unaudited results, standalone and consolidated. No insider pledges, block deals, or corporate actions reported since listing.
What to Watch on Aug 17
1. Revenue run-rate — Is the company tracking the 10-15% FY27 growth path, or is order inflow softening? 2. Margin resilience — Does 12% net margin hold, or has capex deployment, depreciation, or forex whipsaw bitten into profitability? 3. Order book strength — Management commentary on H2 aerospace/defence recovery and automotive momentum will set tone for FY27 trajectory. 4. Capex & working capital — How is IPO capital being deployed? Is NWC ballooning?
INDO-MIM enters Q1 FY27 as the world's largest MIM player with a 14-year track record of 20%+ CAGR, now public and guided to 10-15% FY2027 growth. The quarter is a litmus test: Street confidence hinges on whether the company maintains order inflow discipline and margin stability in a newly liquid, actively traded stock. Expect ~₹1,100-1,150 Cr revenue and ~₹135-150 Cr profit on-plan; the story is in the color — order visibility, capex phasing, and export realisations.
Indo-MIM's debut Q1: consolidated PAT +32% YoY on margin expansion, tops preview
PAT +31.65% YoY · revenue +9.39% · margins expanding · beat vs street
₹1,218.74 Cr
+9.39% YoY
₹240.12 Cr
+31.65% YoY
19.65%
₹4.96
Indo-MIM's first quarterly print since its July 30, 2026 listing came in well ahead of the expectations we flagged pre-result: consolidated revenue of ₹1,218.7 Cr (+9.4% YoY, +16.3% QoQ) and consolidated PAT of ₹240.1 Cr (+31.6% YoY) both topped the preview's ₹1,100-1,150 Cr revenue and ₹135-150 Cr profit ranges, with PAT beating the top of that range by roughly 60-78%. Standalone numbers were softer — revenue ₹1,003.1 Cr (+3.2% YoY) and PAT ₹223.2 Cr (+23.5% YoY) — a gap of more than 6 points on revenue growth and 8 points on PAT growth versus consolidated, indicating the US and UK subsidiaries (Triax Industries, Indo-MIM Inc/México, Conway Marsh Garrett) contributed disproportionately to the quarter's outperformance. Neither the current nor the year-ago quarter carried exceptional items at consolidated or standalone level, so both YoY growth figures are clean, unadjusted comparisons.
Q1 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
The beat was margin-led rather than volume-led: consolidated net profit margin expanded to 19.7% from 16.2% a year earlier, and the core pre-exceptional operating margin rose to 26.7% from 22.0% YoY — roughly 470 basis points of operating leverage even as revenue growth was comparatively modest. The QoQ profit jump (PAT +72.6%) is not comparable like-for-like: the immediately preceding March-26 quarter carried a ₹14.6 Cr consolidated exceptional gain and unusually weak pre-exceptional profit (₹170.8 Cr vs this quarter's ₹325.3 Cr), so QoQ is a base-effect artifact rather than a trend worth headlining.
What the summary numbers don't show
Consolidated basic EPS ₹4.96 (diluted ₹4.87) vs ₹3.78 a year ago — pre-listing IPO-note FY27E EPS estimate was ~₹12.25, so Q1 diluted EPS alone covers roughly 40% of the full-year estimate.
Against management's own framing, the company's guided 10-15% revenue growth band (cited in its pre-IPO note) sits just above this quarter's 9.4% consolidated YoY growth — a marginal miss on topline pace, though only one quarter into that multi-year guide. Profit growth ran well ahead of that band on margin expansion alone. No formal Street consensus exists yet for this print — analyst coverage is still forming post-listing — so today's numbers become the first real data point for FY27 model-building. Corporate developments this quarter were largely listing-related governance housekeeping (Fair Disclosure Code adoption and KMP materiality-disclosure authorization on August 7, trading-window closure from July 30) with no direct numeric tie-in; more financially relevant was the ₹6.80/share aggregate interim dividend (680% of face value, ~₹329.2 Cr cash outflow) paid during the quarter. No management press release or concall commentary was available in our records to cross-check against the print.
W1
Whether revenue growth re-accelerates into the guided 10-15% band — Q1 consolidated YoY growth of 9.4% sits just below the floor.
W2
Durability of the margin expansion (consol NPM 19.7% vs 16.2% YoY) as the base normalizes and formal analyst coverage builds out.
W3
First quarter with a full set of published Street estimates to benchmark against, given coverage was still forming pre-print.